Plain-English translation of NCT07111715 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
This study is testing a new approach to diagnosing Crohn disease using capsule endoscopy โ a small camera pill you swallow that takes pictures inside your small intestine. The study will compare how well artificial intelligence can analyze these pictures versus traditional manual review by doctors. If you have symptoms suggesting Crohn disease but your previous colonoscopy was inconclusive or negative, this trial may help confirm whether you actually have the condition.
Crohn disease can be difficult to diagnose because symptoms overlap with other conditions, and sometimes inflammation is missed on standard tests. Artificial intelligence might help doctors spot signs of inflammation more reliably, leading to faster and more accurate diagnoses for patients who need treatment.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
At a screening visit, you'll complete questionnaires about how your symptoms affect your quality of life, mood, and energy levels. If you meet all requirements, you'll swallow a small camera capsule that travels naturally through your small intestine over 8โ10 hours, taking thousands of pictures. Some patients may first swallow a patency capsule to confirm there are no blockages. The capsule eventually passes through your system naturally. Doctors will review the images using both traditional manual reading and artificial intelligence analysis to look for signs of Crohn disease.
AI-generated summary from trial data ยท Sep 5, 2026 ยท Not medical advice
Italy